Your browser is no longer supported. Please, upgrade your browser.
Settings
NSPR InspireMD, Inc. daily Stock Chart
NSPR [NYSE]
InspireMD, Inc.
Index- P/E- EPS (ttm)-10.57 Insider Own6.79% Shs Outstand3.88M Perf Week-28.16%
Market Cap3.40M Forward P/E17.53 EPS next Y0.05 Insider Trans0.00% Shs Float3.38M Perf Month-31.52%
Income-9.70M PEG- EPS next Q-1.56 Inst Own10.00% Short Float3.61% Perf Quarter-61.39%
Sales3.40M P/S1.00 EPS this Y- Inst Trans28.05% Short Ratio0.46 Perf Half Y-73.84%
Book/sh4.79 P/B0.18 EPS next Y100.60% ROA- Target Price5.00 Perf Year-91.73%
Cash/sh1.86 P/C0.47 EPS next 5Y- ROE- 52W Range0.91 - 11.98 Perf YTD-88.97%
Dividend- P/FCF- EPS past 5Y- ROI-86.50% 52W High-92.69% Beta1.99
Dividend %- Quick Ratio3.60 Sales past 5Y3.00% Gross Margin23.60% 52W Low-3.68% ATR0.12
Employees36 Current Ratio4.10 Sales Q/Q12.50% Oper. Margin- RSI (14)25.58 Volatility16.52% 10.42%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.44 Prev Close0.95
ShortableYes LT Debt/Eq0.00 EarningsNov 12 BMO Payout- Avg Volume267.67K Price0.88
Recom- SMA20-25.29% SMA50-44.14% SMA200-78.30% Volume117,168 Change-7.62%
Jan-07-16Initiated Rodman & Renshaw Buy $4
Mar-13-15Downgrade Oppenheimer Outperform → Perform
Nov-26-13Initiated Oppenheimer Outperform $6
Nov-13-19 08:36AM  Is InspireMD, Inc. (NYSEMKT:NSPR) A Volatile Stock? Simply Wall St. -6.68%
Nov-12-19 07:00AM  InspireMD Announces Third Quarter 2019 Financial Results GlobeNewswire -21.05%
Nov-05-19 08:00AM  InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12 GlobeNewswire +8.47%
Sep-19-19 09:12PM  InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering GlobeNewswire -29.73%
Sep-09-19 08:05AM  InspireMD Provides Business Update GlobeNewswire +11.58%
08:00AM  InspireMD to Present at the HC Wainwright 21st Annual Global Investment Conference GlobeNewswire
Sep-02-19 08:09PM  Edited Transcript of NSPR earnings conference call or presentation 6-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
Aug-26-19 07:42AM  4 Defensible Healthcare Stocks Gaining While the Market Falls TipRanks -18.77%
Aug-09-19 04:30PM  InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency GlobeNewswire
Aug-06-19 07:00AM  InspireMD Announces Second Quarter 2019 Financial Results GlobeNewswire -14.71%
Jul-30-19 04:05PM  InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6 GlobeNewswire
Jul-29-19 10:34AM  InspireMD (NSPR) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Jul-11-19 09:58AM  Do Institutions Own InspireMD, Inc. (NYSEMKT:NSPR) Shares? Simply Wall St.
May-16-19 06:10AM  Edited Transcript of NSPR earnings conference call or presentation 14-May-19 12:00pm GMT Thomson Reuters StreetEvents -7.47%
May-14-19 07:00AM  InspireMD Announces First Quarter 2019 Financial Results GlobeNewswire -15.97%
May-07-19 08:00AM  InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14 GlobeNewswire
Apr-04-19 06:00AM  InspireMD, Inc. Announces Pricing of $2.4 Million Public Offering of Common Stock GlobeNewswire -42.58%
Apr-03-19 04:05PM  InspireMD, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire +25.26%
Apr-01-19 02:00PM  A Reverse Split and Key Demand Drivers for InspireMD's Proprietary Technology ACCESSWIRE -8.71%
Mar-26-19 07:00AM  InspireMD Announces 1-for-50 Reverse Stock Split GlobeNewswire -8.85%
Mar-22-19 06:00PM  InspireMD Provides Amended Disclosure GlobeNewswire
Feb-19-19 07:00AM  InspireMD Announces Fourth Quarter 2018 Financial Results GlobeNewswire -7.50%
Feb-07-19 08:00AM  InspireMD to Report Fourth Quarter and Fiscal 2018 Financial Results and Provide Business Update on Tuesday, February 19 GlobeNewswire +5.99%
Jan-24-19 08:00AM  InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study Comparing CGuard EPS with a Conventional Open-Cell Carotid Stent GlobeNewswire
Jan-23-19 08:00AM  InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard EPS at the Leipzig Interventional Course (LINC) 2019 GlobeNewswire
Jan-22-19 08:00AM  InspireMD Announces Results from Initial Clinical Study of The CGuard Embolic Prevention System (EPS) with SmartFit Technology GlobeNewswire
Jan-18-19 09:34AM  InspireMDs CGuard Embolic Prevention System to be Prominently Featured in Live Case Transmissions at LINC, 22nd to the 25th January 2019, in Leipzig, Germany GlobeNewswire +21.81%
Jan-14-19 08:00AM  InspireMD Announces the Distribution of CGuard Embolic Prevention System in South Africa GlobeNewswire -8.03%
Jan-11-19 04:30PM  InspireMD Receives Noncompliance Notice from NYSE American GlobeNewswire
Dec-18-18 08:00AM  InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems GlobeNewswire
Dec-11-18 11:55AM  What Investors Should Know About InspireMD, Inc.s (NYSEMKT:NSPR) Financial Strength Simply Wall St.
Nov-29-18 08:00AM  InspireMD Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard EPS Registries at the Recent 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium) GlobeNewswire
Nov-28-18 08:00AM  InspireMD Announces Regulatory and Reimbursement Approval of CGuard Embolic Prevention System in Australia GlobeNewswire +6.18%
Nov-15-18 08:00AM  Report: Developing Opportunities within InspireMD, Lakeland Industries, ALJ Regional, Alphatec, Jerash Holdings (US), and DocuSign Future Expectations, Projections Moving into 2018 GlobeNewswire +6.09%
Nov-13-18 08:00AM  InspireMD Announces Upcoming Presentations at the 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium) GlobeNewswire
Nov-06-18 07:00AM  InspireMD Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire -5.43%
Oct-30-18 08:00AM  InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6 GlobeNewswire
Oct-23-18 12:06PM  Does InspireMD Incs (NYSEMKT:NSPR) Past Performance Indicate A Weaker Future? Simply Wall St.
Sep-27-18 09:28AM  InspireMD Announces Presentation of Preliminary Cumulative Three-Year CGuard EPS Safety and Efficacy Data at the Transcatheter Cardiovascular Therapeutics 2018 Conference GlobeNewswire
Sep-24-18 08:00AM  InspireMD Announces Regulatory Approval of CGuard Embolic Prevention System in Mexico GlobeNewswire +8.99%
Sep-17-18 08:00AM  InspireMD Announces Issuance of Two New U.S. Patents Covering Proprietary MicroNet Stent Jacket and Related Drug Eluting Technology GlobeNewswire
Sep-13-18 08:00AM  Today's Research Reports on Trending Tickers: InspireMD and Tandem Diabetes Care ACCESSWIRE -18.51%
Sep-04-18 07:30AM  InspireMD to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York City GlobeNewswire
Aug-06-18 04:05PM  InspireMD Reports 94% Increase in CGuard EPS Revenues for the Second Quarter of 2018 GlobeNewswire +7.44%
Jul-31-18 07:00AM  InspireMD Schedules Second Quarter 2018 Earnings Conference Call GlobeNewswire
Jul-23-18 08:41AM  InspireMD Announces Opening of First Two CGuard EPS Centers of Excellence GlobeNewswire
Jul-10-18 07:30AM  Free Technical Reports on InspireMD and Three Additional Medical Equipment Equities ACCESSWIRE
Jun-29-18 10:24AM  InspireMD, Inc. Announces Pricing of $10 Million Underwritten Public Offering GlobeNewswire -51.38%
Jun-20-18 07:20AM  InspireMDs CGuard EPS Featured at the SBHCI Congress in Brazil GlobeNewswire
Jun-18-18 09:42AM  InspireMDs CGuard EPS Prominently Featured at the 10th International Congress of the Polish Society for Vascular Surgery GlobeNewswire -11.02%
Jun-11-18 09:53AM  InspireMDs CGuard MicroNet EPS Featured in a Live Case Transmission to the 2nd DGA Interventional Congress GlobeNewswire
Jun-04-18 12:18PM  Should You Worry About InspireMD Incs (NYSEMKT:NSPR) CEO Salary Level? Simply Wall St.
07:30AM  Free Daily Technical Summary Reports on LivaNova and Three Other Medical Equipment Stocks ACCESSWIRE
May-30-18 07:31AM  InspireMD Reports on Expanded 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard EPS GlobeNewswire +7.50%
May-24-18 04:27PM  Why You Need To Look At This Factor Before Buying InspireMD Inc (NYSEMKT:NSPR) Simply Wall St. +6.72%
May-16-18 08:12AM  InspireMD Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Ecuador GlobeNewswire +9.09%
May-07-18 04:05PM  InspireMD Reports 132% Increase in CGuard EPS Sales for the First Quarter of 2018 GlobeNewswire
May-02-18 07:50AM  Wired News InspireMD Received Regulatory Approval to Commercialize its Products in Vietnam ACCESSWIRE
May-01-18 07:00AM  InspireMD Schedules First Quarter 2018 Earnings Conference Call GlobeNewswire
Apr-30-18 04:05PM  InspireMD Stock Rallies After Vietnam Approves Embolism Prevention Products Benzinga +12.96%
07:34AM  InspireMD Announces Regulatory Approval and Reimbursement to Commercialize both CGuard EPS and MGuard Prime Products in Vietnam GlobeNewswire
Apr-19-18 07:00AM  InspireMDs CGuard Embolic Prevention System to be Featured at ICCA Stroke 2018 in Warsaw, Poland GlobeNewswire
Apr-03-18 10:28AM  InspireMD Anticipates Fifth Consecutive Quarter of Sequential Double Digit Growth; Projects 132% Increase in CGuard EPS Sales for the First Quarter of 2018; Total Quarterly Company Sales to Exceed $1 Million GlobeNewswire
Mar-29-18 07:30AM  Blog Exposure - InspireMD Announced Regulatory Approval for CGuard Embolic Prevention System and MGuard Prime in Peru ACCESSWIRE -22.96%
Mar-28-18 06:30AM  InspireMD, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock GlobeNewswire -43.75%
Mar-27-18 04:37PM  InspireMD, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire +17.65%
07:00AM  InspireMD Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Peru GlobeNewswire
Mar-08-18 05:07PM  With A -53.98% Earnings Drop, Is InspireMD Incs (NYSEMKT:NSPR) Performance A Concern? Simply Wall St. -5.24%
Mar-05-18 08:07AM  InspireMD Announces First Patient Treated with CGuard EPS in India GlobeNewswire
Mar-01-18 07:30AM  InspireMD Announces Expansion of its Distribution Network GlobeNewswire
Feb-27-18 07:00AM  InspireMD, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire -32.02%
Feb-26-18 04:02PM  InspireMD, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire -7.30%
Feb-23-18 08:20AM  Todays Research Reports on Trending Tickers: InspireMD and Eli Lilly and Company ACCESSWIRE
Feb-22-18 10:16AM  InspireMD Announces Exclusive Distribution, Sales and Marketing Agreement for CGuard EPS in South Korea GlobeNewswire
Feb-20-18 09:00AM  InspireMD Announces Commercial Launch and First Sales of CGuard EPS in India GlobeNewswire -6.50%
Feb-14-18 07:30AM  InspireMD Announces Fourth Quarter and Year-End 2017 Results; CGuard EPS Fourth Quarter Sales Increase 211% Versus Same Period Last year GlobeNewswire +16.01%
Feb-08-18 08:20AM  Todays Research Reports on Trending Tickers: Eli Lilly and Company and InspireMD ACCESSWIRE -7.16%
Feb-07-18 02:36PM  InspireMD Announces 1-for-35 Reverse Stock Split GlobeNewswire -20.62%
Feb-01-18 08:10AM  InspireMD, CGuard is Ramping up Revenues, Business Outlook, and Analysts Review ACCESSWIRE +6.22%
Jan-31-18 08:31AM  InspireMD's CGuard Embolic Prevention System Featured in a Second Live Case Transmission at LINC 2018 by Leading Interventional Cardiologists GlobeNewswire -9.60%
Jan-30-18 08:19AM  InspireMDs CGuard Embolic Prevention System Featured in Successful Live Case Transmissions at LINC 2018 by Leading Vascular Surgeons GlobeNewswire +35.35%
Jan-26-18 10:11AM  InspireMDs CGuard Embolic Prevention System to be Prominently Featured in Two Live Case Transmissions at LINC 2018 GlobeNewswire
Jan-19-18 10:18AM  InspireMD Announces Publication of an Independent Imaging Study Highlighting the Advantages of CGuard EPS Compared to Another Next Generation Carotid Stent GlobeNewswire +13.44%
Jan-10-18 08:20AM  Todays Research Reports on Trending Tickers: Akers Biosciences and InspireMD, Inc. ACCESSWIRE -27.54%
07:30AM  InspireMD Projects 211% Increase in CGuard(TM) EPS Sales for the Fourth Quarter of 2017 GlobeNewswire
Jan-03-18 04:05PM  InspireMD Schedules Conference Call to Discuss Recent Developments, Preliminary Sales Results and Proposals for Upcoming Shareholder Meeting GlobeNewswire +7.15%
02:02PM  2 Medical Technology Stocks That Have Investors' Attention ACCESSWIRE
08:56AM  InspireMD Announces Regulatory Approval of CGuard EPS in India; Signs Agreement with Leading Indian Medical Device Distributor GlobeNewswire
Dec-18-17 12:05PM  InspireMDs CGuard Embolic Prevention System Once Again Featured in a Successful Live Clinical Case at Leading Industry Conference GlobeNewswire
Dec-07-17 12:23PM  InspireMDs CGuard EPS Demonstrates Improved Outcomes over Carotid Endarterectomy in 50 Patient Comparative Study; Preliminary Results Featured at the 7th Munich Vascular Conference 2017 GlobeNewswire +7.82%
Dec-05-17 01:00PM  InspireMD Announces Preliminary 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard EPS GlobeNewswire
Dec-04-17 09:45AM  InspireMD Announces Expansion of its Distribution Network for CGuard EPS in Australia, New Zealand and Vietnam GlobeNewswire +16.30%
Nov-29-17 07:00AM  InspireMD Announces Planned Recapitalization Marketwired -51.29%
Nov-09-17 08:37AM  InspireMD, Inc. :NSPR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017 Capital Cube -5.26%
Nov-07-17 04:05PM  InspireMD Announces Third Quarter 2017 Results; CGuard(TM) Revenue Increases 90% Versus Same Period Last Year Marketwired +5.94%
Nov-03-17 07:59PM  What Does InspireMD Incs (NSPR) Ownership Structure Look Like? Simply Wall St.
Nov-01-17 07:30AM  InspireMD Schedules Third Quarter 2017 Earnings Conference Call Marketwired
Oct-25-17 07:30AM  InspireMD's CGuard(TM) Carotid Embolic Prevention System Featured in Live Case at Cracow Vascular Summit 2017 in Poland Marketwired
Oct-24-17 09:47AM  New York Stock Exchange Accepts InspireMD's Plan to Regain Compliance Marketwired
Oct-12-17 10:35AM  InspireMD Announces Distribution Agreement for MGuard Prime(TM) in Chile Marketwired
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stuka PaulDirectorDec 11Sale0.18651212,746Dec 11 04:07 PM
Kester Thomas JDirectorNov 21Sale0.21820Nov 26 06:10 AM